Home > Publications database > Synthesis of peptoid-based class I selective histone deacetylase inhibitors with chemosensitizing properties |
Journal Article | FZJ-2019-06042 |
; ; ; ; ; ; ; ; ; ;
2019
ACS
Washington, DC
This record in other databases:
Please use a persistent id in citations: doi:10.1021/acs.jmedchem.9b01489
Abstract: There is increasing evidence that histone deacetylase (HDAC) inhibitors can (re)sensitize cancer cells for chemotherapeutics via ‘epigenetic priming’. In this work, we describe the synthesis of a series of class I selective HDAC inhibitors with 2-aminoanilides as zinc-binding groups. Several of the synthesized compounds revealed potent inhibition of the class I HDAC isoforms HDAC1, 2 and/or 3 and promising antiproliferative effects in the human ovarian cancer cell line A2780 and the human squamous carcinoma cell line Cal27. Selected compounds were investigated in a cellular model of platinum resistance. In particular compound 2a revealed potent chemosensitizing properties and full reversal of cisplatin resistance in Cal27CisR cells. This effect is related to a synergistic increase in caspase 3/7 activation and induction of apoptosis. Thus, this work demonstrates that pan-HDAC inhibition or dual class I/class IIb inhibition is not required for full reversal of cisplatin resistance.
![]() |
The record appears in these collections: |